{"name": "Arsanis",
 "permalink": "arsanis",
 "crunchbase_url": "http://www.crunchbase.com/company/arsanis",
 "homepage_url": "http://www.arsanis.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2010,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "office@arsanis.com",
 "phone_number": "",
 "description": "",
 "created_at": "Wed Feb 09 03:32:34 UTC 2011",
 "updated_at": "Mon Apr 08 12:20:21 UTC 2013",
 "overview": "\u003Cp\u003EArsanis, Inc. was incorporated in 2010 and is based in Lebanon, New Hampshire. Arsanis also operates as Arsanis Biosciences in Vienna, Austria, and according to a job posting, the company is focused on developing infectious disease treatments based on similar \u00e2\u20ac\u0153bacterial protein and carbohydrate antigens\u00e2\u20ac\u009d as GlycoFi. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       49],
      "assets/images/resized/0012/4388/124388v1-max-150x150.png"],
     [[248,
       82],
      "assets/images/resized/0012/4388/124388v1-max-250x250.png"],
     [[248,
       82],
      "assets/images/resized/0012/4388/124388v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Co - Founder \u0026 Board Member",
    "person":
     {"first_name": "Errik",
      "last_name": "B. Anderson",
      "permalink": "errik-b-anderson",
      "image":
       {"available_sizes":
         [[[124,
            124],
           "assets/images/resized/0027/1392/271392v1-max-150x150.jpg"],
          [[124,
            124],
           "assets/images/resized/0027/1392/271392v1-max-250x250.jpg"],
          [[124,
            124],
           "assets/images/resized/0027/1392/271392v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Board Director",
    "person":
     {"first_name": "Michael",
      "last_name": "Ross",
      "permalink": "michael-ross-2",
      "image":
       {"available_sizes":
         [[[140,
            140],
           "assets/images/resized/0004/5367/45367v1-max-150x150.jpg"],
          [[140,
            140],
           "assets/images/resized/0004/5367/45367v1-max-250x250.jpg"],
          [[140,
            140],
           "assets/images/resized/0004/5367/45367v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Co - Founder  \u0026 Chairman",
    "person":
     {"first_name": "Tillman",
      "last_name": "Gerngross",
      "permalink": "tillman-gerngross",
      "image":
       {"available_sizes":
         [[[124,
            124],
           "assets/images/resized/0027/1365/271365v1-max-150x150.jpg"],
          [[124,
            124],
           "assets/images/resized/0027/1365/271365v1-max-250x250.jpg"],
          [[124,
            124],
           "assets/images/resized/0027/1365/271365v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$10M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.news-medical.net/news/20110228/Arsanis-closes-Series-A-financing-for-2410-million.aspx",
    "source_description": "Arsanis closes Series A financing for $10 million",
    "raised_amount": 10000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 2,
    "funded_day": 28,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "OrbiMed Advisors",
         "permalink": "orbimed-advisors",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0005/0248/50248v1-max-150x150.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-250x250.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Polaris Partners",
         "permalink": "polaris-partners",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0001/1153/11153v1-max-150x150.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-250x250.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SV Life Sciences",
         "permalink": "sv-life-sciences",
         "image":
          {"available_sizes":
            [[[150,
               50],
              "assets/images/resized/0004/5361/45361v2-max-150x150.png"],
             [[250,
               84],
              "assets/images/resized/0004/5361/45361v2-max-250x250.png"],
             [[332,
               112],
              "assets/images/resized/0004/5361/45361v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Campus Vienna Biocenter 4",
    "address2": "Dr. Bohr-Gasse 3",
    "zip_code": "A-1030",
    "city": "Vienna",
    "state_code": null,
    "country_code": "AUT",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}